Patient Guide: Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 113 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT02951052
Status: ACTIVE_NOT_RECRUITING
Condition: Infection, Human Immunodeficiency Virus, HIV Infections
Phase: PHASE3

Find a Study Location Near You

This study is available at 113 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Birmingham, Alabama
  • • Phoenix, Arizona
  • • Bakersfield, California
  • • And 110 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults - Join Clinical Trial NCTNCT02951052

How to Join This Clinical Trial - NCTNCT02951052

Learn how to participate in this PHASE3 trial studying an investigational therapy for Infection, Human Immunodeficiency Virus, HIV Infections. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Infection, Human Immunodeficiency Virus, HIV Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Infection, Human Immunodeficiency Virus, HIV Infections
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT02951052 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 113 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294 - United States

Status: Contact for availability

Clinical Research Site

Phoenix, Arizona 85015 - United States

Status: Contact for availability

Clinical Research Site

Bakersfield, California 93301 - United States

Status: Contact for availability

Clinical Research Site

Long Beach, California 90813 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90036 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90069 - United States

Status: Contact for availability

Clinical Research Site

Palm Springs, California 92264 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94109 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94110 - United States

Status: Contact for availability

Clinical Research Site

Denver, Colorado 80246 - United States

Status: Contact for availability

And 103 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Infection, Human Immunodeficiency Virus, HIV Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation